B08.3
Erythema infectiosum [fifth disease]
Clinical Classification Guidelines
Medical Intelligence & Overview
Erythema infectiosum, commonly known as fifth disease, is a contagious viral infection that primarily affects children but can also occur in adults. It is characterized by distinctive skin rashes and mild flu-like symptoms. The disease is caused by the parvovirus B19 and spreads through respiratory droplets. While often mild and self-limiting, understanding its symptoms, causes, and treatment options can help in managing the condition effectively.
Causes & Symptoms
Clinical Causes: Infection with parvovirus B19, which is the primary cause of fifth disease. Spread through respiratory droplets from coughing or sneezing of an infected person. Contact with contaminated surfaces or objects that have virus particles on them. Less commonly, from blood transfusions or organ transplants, though this is rare.
Key Symptoms: Low-grade fever, headache, and sore throat in the initial stage. Red, slapped-cheek appearance on the face, giving a distinctive look. Followed by a facial rash that can spread to the body, arms, and legs. Rash may appear as lace-like or reticulated patterns and can be itchy. Mild joint pain or swelling, especially in adults. General fatigue or malaise, which usually resolves as the rash develops.
Diagnostic & Treatment
Diagnosis Path: Diagnosis of fifth disease is primarily clinical, based on the characteristic rash and symptoms. Healthcare providers may confirm the infection through blood tests that detect parvovirus B19 antibodies or viral DNA, especially in atypical cases or when complications are suspected.
Treatment Protocols: There is no specific antiviral treatment for erythema infectiosum. Management typically involves supportive care to relieve symptoms, including rest, hydration, and over-the-counter medications like acetaminophen or ibuprofen for fever and pain. Since the disease is usually mild, recovery occurs on its own within a few weeks. For immunocompromised individuals or pregnant women, medical supervision is essential due to potential complications.
Clinical Advice & FAQs
Billing Guidance
Is B08.3 a billable ICD-10 code?
Yes, B08.3 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report B08.3?
Clinical documentation must specify the nature of Erythema infectiosum [fifth disease] and any associated comorbidities for accurate reporting.
Cite this Clinical Reference